ESC Premium Access

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Congress Session

About the speaker

Professor Ioanna Andreadou

National & Kapodistrian University of Athens, Athens (Greece)
1 presentation
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Thumbnail

STING inhibition in myocardial remodelling following myocardial infarction

Speaker: Doctor L. Rech (Graz, AT)

Thumbnail

Access the full session

Basic science e-posters

Speakers: Professor I. Andreadou, Doctor T. Yamamoto, Doctor C. Lo, Associate Professor G. Rigatelli, Doctor M. Gonotkov...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

DYNAMIC - Riociguat in patients with pulmonary hypertension and heart failure with preserved ejection fraction

27 August 2021

ESC Premium Access

Efficacy of ARNI in real-world

27 August 2021

ESC Premium Access

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

27 August 2021

This platform is supported by

logo Novo Nordisk